|
Jenburkt Pharmaceuticals Ltd.
|
Cash Flow
|
|
|
You can view the
Cash Flow
for the last 5 years.
|
Market Cap. (Rs.)
|
472.25 Cr.
|
P/BV
|
2.40
|
Book Value (Rs.)
|
446.47
|
|
52 Week High/Low (Rs.)
|
1340/944
|
FV/ML
|
10/1
|
P/E(X)
|
13.60
|
|
Bookclosure
|
11/07/2025
|
EPS (Rs.)
|
78.71
|
Div Yield (%)
|
1.93
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | | |
| Net Profit/Loss Before Extraordinary Items And Tax | 46.52 | 32.06 | 25.98 | 24.61 | 22.30 |
| | | | | | |
| Net CashFlow From Operating Activities | 26.52 | 27.91 | 8.12 | 17.05 | 9.40 |
| Net Cash Used In Investing Activities | -19.45 | -17.04 | -0.58 | 2.62 | -1.33 |
| Net Cash Used From Financing Activities | -8.86 | -7.62 | -7.08 | -21.04 | -5.53 |
| | | | | | |
| Net Inc/Dec In Cash And Cash Equivalents | -1.79 | 3.24 | 0.47 | -1.37 | 2.54 |
| Cash And Cash Equivalents Begin of Year | 7.36 | 4.13 | 3.66 | 5.03 | 2.49 |
| Cash And Cash Equivalents End Of Year | 5.58 | 7.36 | 4.13 | 3.66 | 5.03 |